Fiamma Buttitta

9.5k total citations · 3 hit papers
102 papers, 7.1k citations indexed

About

Fiamma Buttitta is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Fiamma Buttitta has authored 102 papers receiving a total of 7.1k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Oncology, 43 papers in Molecular Biology and 41 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Fiamma Buttitta's work include Lung Cancer Treatments and Mutations (37 papers), Cancer-related Molecular Pathways (26 papers) and Cancer Genomics and Diagnostics (23 papers). Fiamma Buttitta is often cited by papers focused on Lung Cancer Treatments and Mutations (37 papers), Cancer-related Molecular Pathways (26 papers) and Cancer Genomics and Diagnostics (23 papers). Fiamma Buttitta collaborates with scholars based in Italy, United States and Switzerland. Fiamma Buttitta's co-authors include Antonio Marchetti, Lara Felicioni, Antonio Chella, Sara Malatesta, Felice Mucilli, Antonio Marchetti, Fabio Barassi, Silvia Pellegrini, Generoso Bevilacqua and Andrea Mezzetti and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and The EMBO Journal.

In The Last Decade

Fiamma Buttitta

100 papers receiving 6.9k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

EGFR Mutations in Non–Small-Cell Lung Cancer: Analysis of a Large Series of Cases and Development of a Rapid and Sensitive Method for Diagnostic Screening With Potential Implications on Pharmacologic Treatment

2005 670 citations Antonio Marchetti, Carla Martella et al. profile →
Increased MET Gene Copy Number Negatively Affects Survival of Surgically Resected Non–Small-Cell Lung Cancer Patients

2009 455 citations Antonio Marchetti, Lara Felicioni et al. profile →
Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Harboring BRAF Mutations

2011 422 citations Antonio Marchetti, Lara Felicioni et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Fiamma Buttitta	3.6k	3.5k	2.9k	2.4k	702	102	7.1k
Antonio Marchetti	2.5k 0.7×	2.7k 0.8×	2.9k 1.0×	2.0k 0.8×	624 0.9×	111	5.8k
Marija Drobnjak	3.9k 1.1×	3.3k 0.9×	2.0k 0.7×	1.3k 0.6×	505 0.7×	41	7.0k
Paul G. Corn	5.1k 1.4×	2.4k 0.7×	3.2k 1.1×	2.1k 0.9×	487 0.7×	190	8.2k
Steve Szabo	4.6k 1.3×	2.8k 0.8×	2.0k 0.7×	3.5k 1.5×	1.6k 2.3×	9	7.6k
J. Guillermo Paez	3.6k 1.0×	4.7k 1.4×	5.4k 1.9×	2.0k 0.8×	537 0.8×	9	8.6k
Tim Forshew	2.6k 0.7×	2.2k 0.6×	2.1k 0.7×	4.1k 1.7×	1.0k 1.4×	34	5.9k
Lukas C. Heukamp	3.4k 1.0×	1.9k 0.5×	1.7k 0.6×	1.5k 0.6×	506 0.7×	175	6.1k
David S. Shames	3.0k 0.8×	2.9k 0.8×	2.4k 0.8×	1.9k 0.8×	455 0.6×	110	6.1k
Young Lim Choi	5.0k 1.4×	5.7k 1.6×	6.8k 2.3×	2.9k 1.2×	1.3k 1.9×	63	10.6k
David S. Rickman	2.8k 0.8×	1.4k 0.4×	1.6k 0.5×	1.6k 0.7×	855 1.2×	63	5.6k

Countries citing papers authored by Fiamma Buttitta

Since Specialization

Citations

This map shows the geographic impact of Fiamma Buttitta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fiamma Buttitta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fiamma Buttitta more than expected).

Fields of papers citing papers by Fiamma Buttitta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fiamma Buttitta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fiamma Buttitta. The network helps show where Fiamma Buttitta may publish in the future.

Co-authorship network of co-authors of Fiamma Buttitta

This figure shows the co-authorship network connecting the top 25 collaborators of Fiamma Buttitta. A scholar is included among the top collaborators of Fiamma Buttitta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fiamma Buttitta. Fiamma Buttitta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

D′Angelo, Emanuela, Íñigo Espinosa, Lara Felicioni, Fiamma Buttitta, & Jaime Prat. (2023). Ovarian high-grade serous carcinoma with transitional-like (SET) morphology: a homologous recombination-deficient tumor. Human Pathology. 141. 15–21. 4 indexed citations

Lazzaro, Carlo, Giovanni Fattore, Massimo Barberis, et al.. (2023). Full cost of diagnostic pathology for lung carcinoma in Italy: results from four Pathology Units. Pathologica. 115(2). 83–89. 2 indexed citations

Fumagalli, Caterina, Elena Guerini‐Rocco, Fiamma Buttitta, et al.. (2020). Reliability and reproducibility among different platforms for tumour BRCA testing in ovarian cancer: a study of the Italian NGS Network. Journal of Clinical Pathology. 74(10). 668–672. 3 indexed citations

Gambale, Elisabetta, et al.. (2017). Extraordinary and prolonged Erlotinib-induced clinical response in a patient with EGFR wild-type squamous lung cancer in third-line therapy: a case report. International Medical Case Reports Journal. Volume 10. 173–175. 1 indexed citations

Marchetti, Antonio, Massimo Barberis, Mauro Papotti, et al.. (2014). ALK Rearrangement Testing by FISH Analysis in Non–Small-Cell Lung Cancer Patients: Results of the First Italian External Quality Assurance Scheme. Journal of Thoracic Oncology. 9(10). 1470–1476. 16 indexed citations

Mandolini, Claudia, Donato Santovito, Pamela Marcantonio, et al.. (2014). Identification of microRNAs 758 and 33b as potential modulators of ABCA1 expression in human atherosclerotic plaques. Nutrition Metabolism and Cardiovascular Diseases. 25(2). 202–209. 34 indexed citations

Gasparini, Giampietro, Fiamma Buttitta, Mario D’Andrea, et al.. (2014). Optimizing Single Agent Panitumumab Therapy in Pre-Treated Advanced Colorectal Cancer. Neoplasia. 16(9). 751–756. 3 indexed citations

Buttitta, Fiamma, Lara Felicioni, Maela Del Grammastro, et al.. (2012). Effective Assessment of egfr Mutation Status in Bronchoalveolar Lavage and Pleural Fluids by Next-Generation Sequencing. Clinical Cancer Research. 19(3). 691–698. 88 indexed citations

Giglio, Simona, Francesca Mancini, Lara Felicioni, et al.. (2005). Identification of an Aberrantly Spliced Form of HDMX in Human Tumors: A New Mechanism for HDM2 Stabilization. Cancer Research. 65(21). 9687–9694. 47 indexed citations

10.

Buttitta, Fiamma, Lara Felicioni, Fabio Barassi, et al.. (2005). PIK3CA mutation and histological type in breast carcinoma: high frequency of mutations in lobular carcinoma. The Journal of Pathology. 208(3). 350–355. 86 indexed citations

11.

Pellegrini, Caterina, Monica Falleni, Antonio Marchetti, et al.. (2003). HER-2/Neu alterations in non-small cell lung cancer: a comprehensive evaluation by real time reverse transcription-PCR, fluorescence in situ hybridization, and immunohistochemistry.. PubMed. 9(10 Pt 1). 3645–52. 97 indexed citations

12.

Marchetti, Antonio, Nicola Tinari, Fiamma Buttitta, et al.. (2002). Expression of 90K (Mac-2 BP) correlates with distant metastasis and predicts survival in stage I non-small cell lung cancer patients.. PubMed. 62(9). 2535–9. 103 indexed citations

13.

Marchetti, Antonella, Silvia Pellegrini, Gabriella Sozzi, et al.. (1998). Genetic analysis of lung tumours of non-smoking subjects: p53 gene mutations are constantly associated with loss of heterozygosity in the FHIT locus. British Journal of Cancer. 78(1). 73–78. 42 indexed citations

14.

Gadducci, Angiolo, M Ferdeghini, Fiamma Buttitta, et al.. (1998). Serum anti-p53 antibodies in the follow-up of patients with advanced ovarian carcinoma.. PubMed. 18(5B). 3763–5. 17 indexed citations

15.

Galimberti, Sara, Andrea Ascoli Marchetti, Fiamma Buttitta, et al.. (1998). Multidrug resistance related genes and p53 expression in human non small cell lung cancer.. PubMed. 18(4C). 2973–6. 22 indexed citations

16.

Sozzi, Gabriella, Laura Sard, Laura De Gregorio, et al.. (1997). Association between cigarette smoking and FHIT gene alterations in lung cancer.. PubMed. 57(11). 2121–3. 151 indexed citations

17.

Marchetti, Antonio, Fiamma Buttitta, Vittoria Carnicelli, et al.. (1997). Enriched SSCP. Diagnostic Molecular Pathology. 6(4). 185–191. 12 indexed citations

18.

Miyazaki, Shukichi, Akira Imatani, L. Ballard, et al.. (1997). The Chromosome Location of the Human Homolog of the Mouse Mammary Tumor-Associated GeneINT6and Its Status in Human Breast Carcinomas. Genomics. 46(1). 155–158. 37 indexed citations

19.

Barbareschi, Mattia, Orazio Caffo, Claudio Doglioni, et al.. (1996). p21WAF1 immunohistochemical expression in breast carcinoma: correlations with clinicopathological data, oestrogen receptor status, MIB1 expression, p53 gene and protein alterations and relapse-free survival. British Journal of Cancer. 74(2). 208–215. 106 indexed citations

20.

Bòsari, Silvano, Antonio Marchetti, Fiamma Buttitta, et al.. (1995). Detection of p53 Mutations by Single-strand Conformation Polymorphisms (SSCP) Gel Electrophoresis. Diagnostic Molecular Pathology. 4(4). 249–255. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact